U.S. Communications Stock News

Amplitude (AMPL) is projected to grow revenue by 12.4% per year, outpacing the broader US market expectation of 10.4%. The company remains unprofitable and is forecast to stay that way over the next three years, with losses having increased at an average rate of 15.4% annually over the past five years. Net profit margin has not improved, and Amplitude has not produced high-quality past earnings. Investors are weighing the potential for rapid revenue growth and an appealing valuation against...

Semrush Holdings (SEMR) is currently unprofitable, but the company has managed to reduce its losses at an average rate of 25.7% per year over the past five years. With forecasts pointing to profitability within three years and earnings expected to grow 117.06% annually alongside 13.8% annual revenue growth, investors are eyeing both the improving trend and SEMR's discounted share price as key rewards in this earnings cycle. See our full analysis for Semrush Holdings. Now, let's see how these...

Pennant Group (PNTG) has continued its strong track record, with earnings forecast to grow by 30.38% per year and revenue expected to rise 16.6% annually, both comfortably ahead of US market averages. Over the past five years, the company delivered annual earnings growth of 29.1%, while profit margins held steady at 3.2%. Investors will note the stock trades at a 30.8x Price-To-Earnings ratio, which is higher than most healthcare peers but below the average of its direct competitors. The...

Borr Drilling (NYSE:BORR) posted standout earnings growth over the last five years, averaging a 56% rise annually and turning profitable with a net profit margin of 7.1% this year, down from 8.7% a year ago. However, the outlook has taken a sharp turn, with analysts projecting earnings to drop by 83.4% per year and revenue to decline 0.4% annually over the next three years. The stock currently trades at $3.21, well below its estimated fair value of $6.44. Its price-to-earnings ratio stands at...

Caris Life Sciences (CAI) is currently unprofitable, with no clear trend in net profit margin or earnings reported for the past year or five years. Analysts forecast revenue growth at an impressive 21% per year and earnings growth of 129.25% per year, predicting the company will reach profitability within three years. Shares currently trade at $24.61, notably below the estimated fair value of $48.22. While its Price-To-Sales Ratio of 10.7x is higher than the US biotech industry average, it...

Albemarle (ALB) remains unprofitable, with reported losses having increased at an average rate of 22.5% per year across the last five years and no improvement shown in net profit margins in its most recent filing. Despite these challenges, the company’s earnings are forecast to rebound sharply at a predicted 66.75% annual growth rate, with profitability expected within three years. Revenue is projected to climb by 8.5% per year, which is slower than the US market average of 10.4%. See our...

Accuray (ARAY) has remained unprofitable, with losses deepening at an annual rate of 28.3% over the past five years. While revenue is projected to grow at 4.4% per year, which is slower than the broader US market’s 10.4% average, earnings are expected to rise sharply at 116.63% per year. This sets the company on course to become profitable within three years. With a Price-To-Sales Ratio of 0.3x and the current share price trading below the estimated fair value of $5.17, investors are keeping...

Ferroglobe (GSM) has narrowed its losses over the past five years, cutting them by 19.5% annually. Although the company remains unprofitable, analysts expect GSM to swing to profitability within three years, with earnings set to grow 118.82% per year and revenue forecast to rise 13.6% per year. Both trends outpace the broader US market. Shares currently trade at $4.14, well below the estimated fair value of $18.98, tilting the balance of rewards toward both value and strong growth...

Enhabit (EHAB) has posted increasing losses over the last five years, with annual losses expanding at a rate of 55.2%. Revenue is expected to grow at 5.5% per year, which trails the 10.4% annual growth forecast for the broader US market. Despite these ongoing losses, EHAB is projected to turn profitable within the next three years. Earnings are forecast to grow at 15.3% annually. See our full analysis for Enhabit. Next, let’s see how these latest figures compare to the narratives commonly...

Talos Energy (TALO) remains unprofitable, with forecasts calling for continued losses over the next three years and revenue projected to decline at an annual rate of 3.4%. Over the past five years, the company has narrowed its losses by 28.1% per year, but has not yet shown improved earnings margins due to persistent negative results. While near-term prospects remain pressured, investors may see potential amid ongoing loss reduction and a significant valuation discount compared to peers. See...

Bumble (BMBL) faces a mixed outlook this earnings season, with revenue forecast to decline by 5.2% per year over the next three years and net losses growing at an annual rate of 61.9% over the past five years. Despite the current losses, earnings are expected to surge by 101.57% annually, with profitability anticipated within the next three years. Investors may view Bumble's below-average Price-to-Sales Ratio and trading price, along with minor risks and a limited risk profile, as potential...

Arko (ARKO) reported a net profit margin of 0.2%, flat compared to last year, as earnings fell by an average of 8.3% per year over the past five years and continued to decline in the most recent period. Revenue is forecast to shrink at a pace of 2.6% per year over the next three years. However, earnings are projected to rebound, with analysts expecting annual growth of 16.5%, which could outpace the broader US market's anticipated 15.8% a year. Despite recent margin pressures and a high...

Adaptive Biotechnologies (ADPT) is forecast to grow its revenue at 13.6% per year, outpacing the broader US market’s 10.4% outlook. Despite this top-line momentum, the company remains unprofitable and is expected to stay in the red for the next three years. Over the last five years, losses have decreased at a rate of 2.6% per year, but net margins have yet to show sustained improvement. See our full analysis for Adaptive Biotechnologies. The next section examines how these results compare...

D-Market Elektronik Hizmetler ve Ticaret (NasdaqGS:HEPS) remains unprofitable, with losses having widened over the past five years at an average rate of 4.4% annually. Despite the ongoing lack of positive net margin, analysts now project a transition to profitability within three years, while revenue is forecast to accelerate at 27.7% per year, well ahead of the broader US market’s 10.4% pace. Coupled with earnings growth expectations of 143.66% per year and a share price of $2.31 trading at...

SunOpta (STKL) has turned profitable, posting average earnings growth of 39% per year over the last five years, though recent figures were affected by a one-off $11.8 million loss that weighed on reported results. Looking ahead, analysts expect the company’s earnings to accelerate at a striking 100.7% annual rate, outpacing the broader US market forecast of 15.8%. Meanwhile, revenue is projected to grow at a slower 7.5% per year compared to the market’s 10.4% average. See our full analysis...

OPENLANE (KAR) posted earnings growth of 427.9% over the past year, a striking leap compared to the five-year average of 27.6% per year. Margins have climbed to 5.8% from 1.2% last year, while the company's annual earnings are forecast to outpace the broader US market with 23.9% growth. With a current share price of $24.94 trading below some estimates of fair value and ongoing questions about financial strength, investors are weighing robust profit expansion against persistent balance sheet...

ZipRecruiter (ZIP) saw its losses deepen at a 37.9% annual rate over the past five years, with the company remaining unprofitable throughout this period. Revenues are projected to grow at 7.4% per year, noticeably slower than the US market average of 10.4% per year. This keeps net profit margins and earnings growth comparisons off the table for now. For investors, the key takeaway is that while shares trade below both industry price-to-sales averages and an indicated fair value of $6.05,...

Sonos (SONO) continues to struggle with profitability, posting losses that have increased at an average rate of 60% annually over the past five years. Despite trading at $16.29 per share, the company's revenue is projected to grow at just 5.5% per year, lagging behind the broader US market's 10.4% pace. Current forecasts point to ongoing unprofitability through at least the next three years. With shares trading above the discounted cash flow-derived fair value and margins showing no sign of...

CSG Systems International (CSGS) delivered earnings growth of 28.1% over the past year, outpacing its 5-year average annual growth of 6.7%. Net profit margins improved to 6.8% from last year’s 5.5%, while earnings are expected to increase at 15.65% per year moving forward. Despite a modest 1.8% forecasted revenue growth that lags the broader US market, the company’s Price-to-Earnings ratio of 24.4x looks compelling against both industry and peer averages. The combination of accelerated...

Figma (FIGMA) posted annual revenue growth of 18.5%, outpacing the US market average of 10.4%. However, the company remains unprofitable and is expected to stay in the red for at least the next three years. The current share price of $45.98 trades at a premium to estimated fair value. Investors are eyeing Figma’s high growth trajectory, but persistent losses and a lofty price-to-sales ratio are putting its valuation under the microscope. See our full analysis for Figma. Now, let’s see how...

Ocugen (OCGN) is projected to deliver rapid revenue growth of 75.3% per year, with earnings expected to rise 77.45% annually, both far exceeding the broader US market estimates. The company remains unprofitable, having posted a 3.8% average annual increase in losses over the past five years, and its share price currently trades at $1.38. Investors will weigh these aggressive growth forecasts against Ocugen’s continued net margin struggles and premium valuation, especially given a...

PTC (PTC) reported a surge in earnings, growing by 96.9% over the past year, pushing average annual earnings growth to 13.3% over the last five years. Net profit margins jumped to 27.1% from 16.4% a year ago, while forecasts point to annual earnings growth of 5.9% moving forward. Investors are likely to focus on the improved profitability, five identified reward factors, and favorable value indicators set against more modest growth forecasts compared to the broader US market. See our full...

Nextdoor Holdings (NXDR) remains unprofitable, with losses increasing at a rate of 2.5% per year over the past five years. While revenue is forecast to grow at 7.8% per year, this trails the broader US market’s expected pace of 10.4% per year. For investors, shares are currently trading at $1.67, below an estimated fair value of $3.48. However, profitability challenges and a higher-than-average Price-To-Sales ratio compared to peers continue to weigh on the outlook. See our full analysis for...

HubSpot (HUBS) remains unprofitable but has steadily narrowed its losses at a rate of 15.8% per year over the past five years. With earnings set to grow by 54.91% annually and profitability expected within three years, investors are watching closely as revenue projections call for 14.4% yearly growth, outpacing the broader US market average of 10.4%. The company's price-to-sales ratio of 7x is below rival averages, rounding out a rewards-heavy outlook that depends on sustained expansion and...